SalivIQ Diagnostics Inc.

Biotechnology · HARRISONBURG, VA

BiotechnologySEC Form D

SalivIQ Diagnostics Inc. filed a Form D with the U.S. Securities and Exchange Commission on June 10, 2026, reporting $1,205,000 raised toward a $2,470,000 offering.

Incorporated in Delaware and based in HARRISONBURG, VA, it operates in the Biotechnology sector.

Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that SalivIQ Diagnostics Inc. has raised capital from private investors.

Browse more recently funded companies in Biotechnology.

Executives & Directors

  • Julia Ann HaltermanExecutive Officer · Director
  • Gregory BellDirector

Recently funded in Biotechnology

Other companies that recently filed a Form D

$7.0MRaised

Ovelle Bio Corp.

BiotechnologyDOVER, DE
Jun 2, 2026View SEC Form D
$29.0KRaised

Thiogenesis Therapeutics, Corp.

BiotechnologyTORONTO, A6
Jun 1, 2026View SEC Form D
$55.8MRaised

Contraline, Inc.

BiotechnologyCHARLOTTESVILLE, VA
May 29, 2026View SEC Form D
$22.9KRaised

Conexeu Sciences Inc.

BiotechnologyRENO, NV
May 28, 2026View SEC Form D
$100.0KRaised

Barricade Therapeutics Corp

BiotechnologyFORT WORTH, TX
May 27, 2026View SEC Form D